Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
9.26
-0.24 (-2.53%)
At close: Apr 28, 2026, 4:00 PM EDT
9.15
-0.11 (-1.19%)
After-hours: Apr 28, 2026, 7:52 PM EDT

Climb Bio Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Climb Bio stock have an average target of 16.82, with a low estimate of 8.00 and a high estimate of 26. The average target predicts an increase of 81.64% from the current stock price of 9.26.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $8.00 $16.82 $17 $26
Change -13.61% +81.64% +83.59% +180.78%

Analyst Ratings

The average analyst rating for Climb Bio stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy 233366
Buy 333456
Hold 000000
Sell 000000
Strong Sell 000000
Total 56671112

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Oppenheimer
Oppenheimer
Buy
Maintains
$10$18
Buy Maintains $10$18 +94.38% Apr 21, 2026
Mizuho
Mizuho
Buy
Initiates
$18
Buy Initiates $18 +94.38% Apr 15, 2026
BTIG
BTIG
Strong Buy
Reiterates
$8
Strong Buy Reiterates $8 -13.61% Apr 8, 2026
B. Riley Securities
B. Riley Securities
Strong Buy
Initiates
$26
Strong Buy Initiates $26 +180.78% Mar 24, 2026
Truist Securities
Truist Securities
Strong Buy
Initiates
$17
Strong Buy Initiates $17 +83.59% Mar 18, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.10
from -0.90
EPS Next Year
-1.28
from -1.10
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
-------
Revenue Growth
-------
EPS
-4.24-1.72-1.30-1.53-0.90-1.10-1.28
EPS Growth
-------
Forward PE
-------
No. Analysts -----1414
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20262027202820292030203120322033
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20262027202820292030203120322033
High - -
Avg - -
Low - -

EPS Forecast

EPS 20262027202820292030203120322033
High -0.98 -1.17
Avg -1.10 -1.28
Low -1.18 -1.48

EPS Growth

EPS Growth 20262027202820292030203120322033
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.